Tag Archives: peritoneal mesothelioma

Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy

longer mesothelioma survival

There is evidence that repeatedly rinsing the abdomen with medicine might lead to longer mesothelioma survival after surgery. A rinse of heated chemotherapy drugs during surgery has become standard of care for peritoneal mesothelioma. Unfortunately, mesothelioma usually comes back. But a top mesothelioma doctor says longer mesothelioma survival might be possible if patients got regular chemotherapy “rinses” through a catheter. Studies show the drugs may not even have to be heated to work. Longer Mesothelioma Survival After Surgery Peritoneal mesothelioma is a type of asbestos cancer. It starts on the lining around the abdomen and can spread to other parts of the body. About a fifth of mesothelioma patients have this type. Heated intraperitoneal chemotherapy (HIPEC) has led to longer … Continue reading Longer Mesothelioma Survival Possible with Long-Term Local Chemotherapy »

Researchers Name Six Top Mesothelioma Survival Factors

Certain factors lead to longer mesothelioma survival

Researchers at the University of Pittsburgh have named what they say are the top six mesothelioma survival factors. According to their new study, patients with one or more of these factors tend to have better mesothelioma treatment outcomes and live longer. Malignant mesothelioma – also called asbestos cancer – is one of the deadliest forms of cancer. It starts on internal membranes and spreads quickly. There is no cure and the disease is very hard to slow down. Many mesothelioma patients die within 12 to 18 months. But there are cases of much longer mesothelioma survival. Some patients have even lived for decades after mesothelioma treatment. The Pittsburgh researchers wanted to find the mesothelioma survival factors shared by the longest … Continue reading Researchers Name Six Top Mesothelioma Survival Factors »

Immunotherapy for Peritoneal Mesothelioma: New Drug Trial Begin

immunotherapy for peritoneal mesothelioma

Researchers in Maryland and Missouri have started human testing of a new type of immunotherapy for peritoneal mesothelioma. If the human trial of this new CAR T-cell therapy goes as well as the laboratory tests, this could be good news for many people with asbestos cancer. CAR stands for chimeric antigen receptor. CAR T-cell therapy works by “reprogramming” a patient’s immune system to fight cancer cells. Tests show this therapy can work well for blood-based cancers like leukemia. But the results have not been as good for solid tumors like peritoneal mesothelioma. MaxCyte is the American company than makes the new drug. They are hoping that their approach to immunotherapy for peritoneal mesothelioma will be better. Preparing CAR T-cell Therapy … Continue reading Immunotherapy for Peritoneal Mesothelioma: New Drug Trial Begin »

Extended Survival of Peritoneal Mesothelioma with Repeat Treatment

There is some good news on the research front for patients with recurrent peritoneal mesothelioma. Doctors at the University of New South Wales in Australia say that treating these patients again with surgery and heated chemotherapy is extending lives, sometimes for several years. Peritoneal mesothelioma, which accounts for about 20 percent of mesothelioma cases, occurs on the peritoneal membrane that surrounds abdominal organs. Cytoreductive surgery (CRS) aims to remove as much of that diseased tissue as possible. It is often followed by heated intraperitoneal chemotherapy (HIPEC) to kill any remaining mesothelioma cells and to keep new tumors from starting. The CRS/HIPEC combination has become the gold standard first line treatment for peritoneal mesothelioma. But the authors of a new study … Continue reading Extended Survival of Peritoneal Mesothelioma with Repeat Treatment »

Peritoneal Mesothelioma Survival May Depend on Cancer Location

physician and colleagues

Doctors in Greece believe they have found a more effective way to predict prognosis and perhaps extend the lives of people with peritoneal mesothelioma and other cancers affecting the peritoneum. It is based around a system than maps the location of cancer within the abdomen. Peritoneal mesothelioma is a rare form of one of the rarest cancers. Caused almost exclusively by asbestos exposure, peritoneal mesothelioma starts on the lining that surrounds the abdominal organs. A combination treatment of surgery followed by a wash of heated chemotherapy (HIPEC) through the abdomen is considered the gold standard therapy. Now, surgical oncologist John Spiliotis of the Metaxa Cancer Hospital in Piraeus, Greece along with colleagues in Greece and the US say the location … Continue reading Peritoneal Mesothelioma Survival May Depend on Cancer Location »

Surgical Experience Improves Outcomes in Peritoneal Mesothelioma

When it comes to surgical intervention for peritoneal mesothelioma, the most experienced centers tend to have the best outcomes. The latest study to support this idea comes from researchers in the Peritoneal Malignancy Institute in Basingstoke, UK. The authors of the new study on peritoneal malignancies including mesothelioma published their research in the British medical journal Colorectal Disease. They performed a retrospective analysis on a database of 1,200 patients treated for peritoneal cancers since 1994. Most of these patients had a diagnosis of cancer of the appendix, but just over 5 percent had peritoneal mesothelioma. The goal of the study was to determine trends in cancer survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). For peritoneal mesothelioma, the surgery involves … Continue reading Surgical Experience Improves Outcomes in Peritoneal Mesothelioma »

Refining CRS-HIPEC for Peritoneal Mesothelioma

Surgery for Peritoneal Mesothelioma

  Three new international studies are helping to refine a treatment for peritoneal mesothelioma that involves rinsing the body cavity with heated chemotherapy drugs. The treatment, called heated intraperitoneal chemotherapy or HIPEC, begins with surgery to remove as much of the mesothelioma tumor as possible from the surface of the peritoneal membrane. Chemotherapy drugs are then heated and rinsed through the area while the patient is still in surgery. The goal is to destroy any residual cancer cells and keep mesothelioma from growing back. Although the treatment is still relatively new, it is quickly becoming the standard of care for peritoneal mesothelioma. Now, researchers around the world are working on ways to make HIPEC even more effective. In one new … Continue reading Refining CRS-HIPEC for Peritoneal Mesothelioma »

Could Your Hairdryer Cause Mesothelioma?

A recent issue of the International Journal of Occupational and Environmental Health contains some sobering news for hairstylists. A frightening new report highlights the potential link between the frequent use of hairdryers and a higher risk of deadly malignant mesothelioma. Hairdressers are not typically counted among the occupations at elevated risk for mesothelioma. Construction workers, electricians, plumbers, and others who work with asbestos-containing insulation have the highest incidence of mesothelioma, which is caused by inhaling the tiny fibers. But the same qualities that make asbestos such a good insulator in construction products, also make it ideal as an insulator and heat shield inside hairdryers. Hundreds of models from almost every major manufacturer were once made with asbestos. The asbestos heat shields were … Continue reading Could Your Hairdryer Cause Mesothelioma? »

New Treatments Have Improved Outcomes for Peritoneal Mesothelioma

The newest studies on peritoneal mesothelioma indicate that the outlook for people with this rare asbestos-linked cancer are better than ever. A recent article in the World Journal of Gastroenterology detailed the progress that has been made – and continues to be made – in the treatment of peritoneal mesothelioma in the last decade. Peritoneal mesothelioma is a type of mesothelioma that occurs on the peritoneum, the lining around the abdominal organs. It accounts for less than a third of mesothelioma cases. In the new article, surgeons with Virginia Commonwealth University’s School of Medicine and the Massey Cancer Center in Richmond report that the increasing use of cytoreductive surgery combined with a rinse of heated chemotherapy drugs has significantly improved … Continue reading New Treatments Have Improved Outcomes for Peritoneal Mesothelioma »

Repeat CRS/HIPEC Improves Survival for Peritoneal Mesothelioma

One of the country’s top peritoneal mesothelioma surgeons has just published a study that may be good news for patients with this aggressive malignancy. Paul Sugarbaker, MD, and colleagues at the Program in Peritoneal Surface Oncology in Washington, DC studied patients with diffuse peritoneal mesothelioma who had repeated cytoreductive surgery and heated intraperitoneal chemotherapy. Their results indicate that patients with diffuse peritoneal mesothelioma can safely undergo these procedures more than once and may even improve their odds of survival. Cytoreductive surgery refers to a surgery designed to remove as much as possible of a mesothelioma tumor growing on the peritoneal lining that surrounds abdominal organs. Doctors have gotten good results by following the procedure with a wash of heated chemotherapy … Continue reading Repeat CRS/HIPEC Improves Survival for Peritoneal Mesothelioma »